UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

Form 10Q-SB
Amended

Quarterly Report Pursuant to Section 13 or 15(d) of the
Securities and Exchange Act of 1934

For the Period ended March 31, 2000

Commission file number: 0-30380

                        Diabetex International Corporation
                 -------------------------------------------------
                 (Exact name of registrant as specified in charter

Nevada                                      87-065234
- ----------------------                   ------------------------
(State or other jurisdiction of         (IRS Employe
incorporation or organization)           Identification No.

142 Ferry Road, Suites 1 & 2, Old Saybrook, Ct.    0647
- -----------------------------------------------   -----------------
(Address of principal executive offices)           (Zip Code

Registrant's telephone number including area code:(860)395-193

Indicate by check mark whether the registrant (1) has filed all report
required to be filed by Section 13 or 15(d) of the Securities
Exchange Act of 1934 during the preceding 12 months (or for such shorter
period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days
                Yes [X]            No [
Indicate the number of shares outstanding of each of the issuer's classes
of common stock, as of the last practical date
      March 31, 2000   Common Shares 13,201,599 at par value $.001

PART 1 FINANCIAL INFORMATION

	Diabetex International Corporation and Subsidiaries

	Consolidated Financial Statement

	March 31, 200










INDEPENDENT AUDITOR'S REPORT


To the Board of Directors and Stockholders of
Diabetex International Corporation
Salt Lake City, Utah


We have reviewed the accompanying consolidated balance sheet of Diabetex
International Corporation and subsidiary as of March 31, 2000 and the related
consolidated statements of income, stockholders' equity and cash flows for the
period then ended.   These financial statements are the responsibility of the
company's management.

We conducted our review in accordance with standards established by the
American Institute of Certified Public Accountants.  A review of interim
financial information consists principally of applying analytical procedures to
financial data and making inquiries of persons responsible for financial and
accounting matters.  It is substantially less in scope than an audit conducted
in accordance with generally accepted auditing standards, the objective of
which is the expression of an opinion regarding the financial statements take
as a whole.  Accordingly, we do not express such an opinion.

Based on our review, we are not aware of any material modifications that should
be made to the condensed consolidated financial statements referred to above for
them to be in conformity with generally accepted  accounting principles.

We have previously audited, in accordance with generally accepted auditing
standards, the balance sheet as of December 31, 1999, and the related
statements of income, stockholders' equity and cash flows for the year the
ended; and in our report dated April 12, 2000, we expressed an unqualified
opinion on those financial statements.

The accompanying statements of operations and cash flows for the period ended
March 31, 1999 were not audited or reviewed by us and, accordingly, we do no
express an opinion on them.


Crouch, Bierwolf & Chishol
May 16, 200

















	Diabetex International Corporation and Subsidiar
	(A Development Stage Company
	Consolidated Balance Sheet


  STOCKHOLDERS' EQUITY
                                                        Accumulated
                                           Capital in   Deficit Durin
                            Common  Common Excess of    Retained
                            Shares  Stock  Par Value    Deficit
Stockholders' Equit
                                              
Activity from Sept. 14, 1983
thru Dec. 31, 1990	             862 $   2 $   94,173 	$  (  96,973)

Loss for 1990                    -      -         -      (     130)
Balance, December 31, 1990      862     2     94,173 	   (  97,103)

Issues 225 shares to a
officer in cancellation of debt
at $16.77 per share            225      1      3,772           -

Loss for the Year               -       -         -       (   3,333)
Balance, December 31, 1991   1,087      3      97,945     ( 100,436)

Expenses paid on the Company'
 behalf contributed to capital  -       -       2,666          -

March 5, 1992, issued 1,25
shares for services rendered
 for $8 per share            1,250      2       9,998          -

Loss for the Year                -      -           -     (   10,278)
Balance, December 31, 1992   2,337      5     110,609 	   (  110,714)

Loss for the Year                -      -           -     (      136)
Balance, December 31, 1993   2,337      5     110,609     (  110,850)

October 17, 1994, issue
25,000 shares for expenses paid
 on the Company's behalf for
 $.84 per share            25,000      50       20,950          -

Expenses paid on the Company's
behalf contributed to capital   -       -          612          -

Loss for the Year               -       -            -    (   22,903)
Balance, December 31, 1994  27,337      55      132,171   (  133,753)

Expenses paid on the Company'
behalf contributed to capital  -        -         1,227            -

Loss for the Year              -        -            -    (      100)
Balance, December 31, 1995  27,337      5      133,398    (  133,853)

Loss for the Year	             -        -            -    (      100)
Balance, December 31, 1996  27,337     55      133,398    (  133,953)


  STOCKHOLDERS' EQUITY -CONTINUE
                                                           Accumulated
                                           Capital in      Deficit During
                        Common      Common Excess of       Retained
                        Shares      Stock  Par Value       Deficit
Stockholders' Equity
                                                
Balance, December 31, 1996  27,337  $   55 $  133,398  $   (  133,953)

Shares issued for assets
of Aladdin Transportation
Landmark, Inc. and Over 100
Inc. for $0 per share      82,500      165   (    165)           -

Shares issued for incentives for
loans to Aladdin Transportation,
Landmark, Inc. and Over 100, Inc.
for $.80 per share         25,163       50       20,081           -

Shares canceled by various
shareholders             (  10,000) 	  ( 20)         20 		        -

Shares canceled for acquisition on
Aladdin Transportation, Landmark
Inc. and Over 100, Inc.  (  82,500)	  (  165)        165 		       -

Shares issued for Presidential an
Regal Limousine Service for $0
per share                    4,000 	        8        (  8)        	-

Shares canceled for Presidentia
and Regal Limousine Service( 4,000)       ( 8)           8 	       -

Net Loss for the Year           -           -            -     (   23,031)

Balance, December 31, 1997  42,500 	       85      153,499     (  156,984)

Rounding due to reverse
stock split (Note 2)	           11          -            -             -

Net Loss for the Year            -          -            -      (    650)

Balance, December 31, 1998  42,511         85       153,499     ( 157,634)


  STOCKHOLDERS EQUITY - CONTINUE
                                                        Accumulated
                                         Capital in     Deficit During
	                        Common   Common Excess of      Retained
	                        Shares   Stock  Par Value      Deficit
Shareholders' Equity
                                             
Balance, December 31,1998  42,511 $   85 $    153,499  $     ( 157,634)

Shares issued for cash at $.002
per share                8,387,800  16,775   	    530               -

Shares issued for services at $.0
per share (Note 2)	      2,000,000	  4,000      96,000              -

Shares issued for cash at $.05
per share                  875,100   1,750       45,767             -

Shares issued for services at $3
per share (Note 2)	         50,000	    100       149,900	           -

Shares issued for cash at $10
per share	                   1,000	      2         2,998	           -

Shares issued for cash at $10
per share                    21,307     43        213,027  	        -

Shares issued for 100% of
shares of Advanced Metabolic
Technology at $10 per
share (Note 3)	           1,232,261   2,465    12,320,145  	        -

Shares issued for intellectual
properties Hamilton-May, Inc
at $10 per share (Note 3)   300,000     600     2,999,400	          -

Expenses paid by shareholder in
Company behalf	                   -        -        4,050           -

Shares issued to Phoenix Energy
(Note 3)                     35,000       70       349,930 	        -

Shares issued for services a
$10. (Note 2)	               12,500	       25	     124,975          -

Shares issued for cash at $10 3,450         7	      34,493          -

Shares issued for services a
$9.00 (Note 2)              150,000        300	   1,349,700         -

Net Loss for the Year             -          -            -    ( 3,002,116)

Balance, December 31,1999 13,110,929 $  26,222  $ 17,844,414  $(  3,159,750)


	(continued

	Diabetex International Corporation and Subsidiar
	(A Development Stage Company
	Consolidated Statements of Stockholders' Equit
	(continued


-----END PRIVACY-ENHANCED MESSAGE-----